Recent Finacing
Recent Raise
ProteoMediX is a Zurich-based diagnostics company developing non-invasive IVD tests for prostate cancer detection, prognosis, and therapy selection, including a biopsy-decision aid for men with elevated PSA or suspicious DRE.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
